HF
ORKA

HRT Financial’s Oruka Therapeutics ORKA Stock Holding History

HRT Financial’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-46,511
Closed -$477K – 3719
2025
Q1 		$477K Buy
+46,511
New +$580K ﹤0.01% 1486
2024
Q2 		– Sell
-1,060
Closed -$22K – 3276
2024
Q1 		$22K Buy
+1,060
New +$21.1K ﹤0.01% 2007
2023
Q2 		– Sell
-1,201
Closed -$28K – 3426
2023
Q1 		$28K Buy
+1,201
New +$31.6K ﹤0.01% 2162

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HRT Financial's ORKA Position: Q2 2025 in Review

HRT Financial sold out of Oruka Therapeutics (ORKA) in Q2 2025, closing a stake of 46,511 shares — an estimated $477K sold.

HRT Financial first reported a position in ORKA in Q1 2023 and held it in 3 quarters. The position peaked at $477K in Q1 2025. 81 funds tracked by Wall St. Rank hold ORKA as of Q2 2025.

  • HRT Financial reported no remaining Oruka Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 46,511 Oruka Therapeutics shares in Q2 2025, an estimated $477K.
  • HRT Financial first reported a position in Oruka Therapeutics in Q1 2023 and held it in 3 quarters.
  • HRT Financial's Oruka Therapeutics position peaked at $477K in Q1 2025.
  • 81 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.